Figure 3.
NYHAbaseline class (A), NT‐proBNPbaseline (B), and eGFRbaseline (C) were significantly predictors of the outcome. (A) Analysis adjusted by baseline values of eGFR‐MDRD method, and NT‐proBNP, and ∆α‐endorphin, ∆‐Log‐Ɣ‐endorphin, and ∆‐sNEP. (B) Analysis adjusted by baseline values of NYHA class and eGFR‐MDRD method, and ∆α‐endorphin, ∆‐Log‐Ɣ‐endorphin, and ∆‐sNEP. (C) Analysis adjusted by baseline values of NYHA class, and NT‐proBNP, and ∆α‐endorphin, ∆‐Log‐Ɣ‐endorphin, and ∆‐sNEP. eGFR, estimated glomerular filtration index; NT‐proBNP, N‐terminal pro‐brain natriuretic peptides; NYHA, New York Heart Association; sNEP, soluble neprilysin; ∆, 30‐day minus baseline.